Antifibrinolytic Agents in Traumatic Hemorrhage A LARGE SCALE RANDOMIZED CONTROLLED TRIAL IS NEEDED

摘要

For people at ages 5 to 45 years, trauma is second only to HIV/AIDS as a cause of death. Each year, worldwide, over 3 million people die as a result of trauma, many after reaching hospital (1). Among trauma patients who do survive to reach hospital, exsanguination is a common cause of death, accounting for nearly half of in-hospital trauma deaths (2). Central nervous system injury and multiorgan failure account for most of the remainder, both of which can be exacerbated by severe bleeding (3).